ask="2.14"
ask_size="300"
average_daily_volume="221198"
bid="1.45"
bid_size="5000"
book_value="0.34"
change="+0.05"
change_from_200_day_moving_average="-0.23"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-3.42"
change_From_52_week_low="0.57"
change_in_percent="+3.07%"
close="1.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.68"
high_52_weeks="5.10"
last_trade_date="1/3/2017"
last_trade_price="1.68"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.43"
low_52_weeks="1.11"
market_capitalization="16.10M"
moving_average_200_day="1.91"
moving_average_50_day="1.67"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.91%"
percent_change_from_50_day_moving_average="+0.66%"
percent_change_from_52_week_high="-67.06%"
percent_change_from_52_week_low="+51.35%"
previous_close="1.63"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.81"
price_per_sales="30.70"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="EYEG"
volume="228945"
weeks_range_52="1.11 - 5.10"
